Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury

Annals of the New York Academy of Sciences

Volumn 1035, Issue , 2004, Pages 165-178

  Reynolds, David N ^a   Smith, Scott A ^a   Zhang, Yi P ^a   Mengsheng, Qiu ^a   Lahiri, Debomoy K ^b   Morassutti, Dante J ^a   Shields, Christopher B ^a   Kotwal, Girish J ^a,c  

^a University of Louisville School of Medicine   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Inflammation; Spinal cord injury; Vaccinia virus complement control protein

Indexed keywords

HEPARIN; UNCLASSIFIED DRUG; VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFECT; HINDLIMB; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MOTOR PERFORMANCE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAIN; RAT; SPINAL CORD INJURY; TREATMENT OUTCOME; UNITED STATES;

ANIMALIA; VACCINIA; VACCINIA VIRUS;

EID: 14944344788     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1332.011     Document Type: Conference Paper

References (30)

1. DUMONT, R.J., D.O. OKONKWO, S. VERMA, et al. 2001. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin. Neuropharmacol. 24: 254-264.
2. ANDERSON, A.J. 2002. Mechanisms and pathways of inflammatory responses in CNS trauma: spinal cord injury. J. Spinal Cord Med. 25: 70-79.
3. FITCH, M.T., C. DOLLER, C.K. COMBS, et al. 1999. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19: 8182-8198.
4. MCDONALD, J.W. 1999. Repairing the damaged spinal cord. Sci. Am. 281: 64-73.
5. BRACKEN, M.B. 2001. Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. Spine 26: S47-S54.
6. HURLBERT, R.J. 2000. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J. Neurosurg. 93: 1-7.
7. HURLBERT, R.J. 2001. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine 26: S39-S46.
8. KOTWAL, G.J. & B. MOSS. 1988. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335: 176-178.
9. KOTWAL, G.J., S.N. ISAACS, R. MCKENZIE, et al. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250: 827-830.
10. MCKENZIE, R., G.J. KOTWAL, B. MOSS, et al. 1992. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166: 1245-1250.
11. KOTWAL, G.J., C.G. MILLER, D.E. JUSTUS. 1998. The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation. Mol. Cell Biochem. 185: 39-46.
12. KOTWAL, G.J., D.N. REYNOLDS, K.L. KEELING, et al. 1998. Vaccinia virus complement control protein is a virokine with lysozyme-like heparin-binding activity: possible implications in prolonged evasion of host immune response. In Proceedings of the 10th International Congress of Immunology. G.P. Talwar & I. Nath, Eds.: 315-320. Monduzzi Editore Pub. Bologna, Italy.
13. REYNOLDS, D.N., K.L. KEELING, R. MOLESTINA, et al. 1999. Heparin binding activity of vaccinia virus protein confers additional properties of uptake by mast cells and attachment to endothelial cells. In Advances in Animal Virology. S. Jameel & J.D. Lambis, Eds.: 343-348. Oxford & IBH Pub. New York.
14. HICKS, R.H., K.L. KEELING, M.Y. YANG, et al. 2002. Vaccinia virus complement control protein enhances functional recovery after traumatic brain injury. J. Neurotrauma 19: 705-714.
15. MURTHY, K.H., S.A. SMITH, V.K. GANESH, et al. 2001. Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell 104: 301-311.
16. SMITH, S.A., N.P. MULLIN, J. PARKINSON, et al. 2000. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74: 5659-5666.
17. GRUNER, J.A. 1992. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 9: 123-126.
18. BASSO, D.M., M.S. BEATTIE, J.C. BRESNAHAN. 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139: 244-256.
19. BASSO, D.M., M.S. BEATTIE, J.C. BRESNAHAN. 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12: 1-21.
20. MAGNUSON, D.S., T.C. TRIDER, Y.P. ZHANG, et al. 1999. Comparing deficits following excitotoxic and contusion injuries in the thoracic and lumbar spinal cord of the adult rat. Exp. Neurol. 156: 191-204.
21. REYNOLDS, D.N., S.A. SMITH, C.B. SHIELDS, et al. 2003. Vaccinia virus complement control protein reduces neutrophil infiltration following spinal cord injury. Ann. N.Y. Acad. Sci. 1010: 534-539.
22. FAROOQUE, M., J. ISAKSSON, Y. OLSSON. 1999. Improved recovery after spinal cord trauma in ICAM-1 and P-selectin knockout mice. Neuroreport 10: 131-134.
23. LACROIX, S., L. CHANG, S. ROSE-JOHN, et al. 2002. Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J. Comp. Neurol. 454: 213-228.
24. LIU, Y., T. TACHIBANA, Y. DAI, et al. 2002. Heme oxygenase-1 expression after spinal cord injury: the induction in activated neutrophils. J. Neurotrauma 19: 479-490.
25. POPOVICH, P.G., P. WEI, B.T. STOKES. 1997. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377: 443-464.
26. POPOVICH, P.G., Z. GUAN, P. WEI, et al. 1999. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158: 351-365.
27. POPOVICH, P.G. & W.F. HICKEY. 2001. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J. Neuropathol. Exp. Neurol. 60: 676-685.
28. POPOVICH, P.G., Z. GUAN, V. MCGAUGHY, et al. 2002. The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. 61: 623-633.
29. WATANABE, T., T. YAMAMOTO, Y. ABE, et al. 1999. Differential activation of microglia after experimental spinal cord injury. J. Neurotrauma 16: 255-265.
30. BEHRMANN, D.L., J.C. BRESNAHAN, M.S. BEATTIE. 1994. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp. Neurol. 126: 61-75.